Axelrod RS - Search Results

1

Axelrod RS. Axelrod RS. Compr Ther. 1997 Aug;23(8):539-45. Compr Ther. 1997. PMID: 9283743 Review.

2

Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab.

Zaorsky NG, Sun Y, Wang Z, Palmer J, Fortina PM, Solomides C, Werner-Wasik M, Dicker AP, Axelrod R, Campling B, Evans N 3rd, Cowan S, Lu B. Zaorsky NG, et al. Cancer Biol Ther. 2013 Oct 1;14(10):883-7. doi: 10.4161/cbt.25942. Epub 2013 Aug 2. Cancer Biol Ther. 2013. PMID: 23917487 Free PMC article.

3

Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma.

Glass J, Silverman CL, Axelrod R, Corn BW, Andrews DW. Glass J, et al. Am J Clin Oncol. 1997 Jun;20(3):226-9. doi: 10.1097/00000421-199706000-00002. Am J Clin Oncol. 1997. PMID: 9167741 Clinical Trial.

4

Clinical results and immunologic effects of a mixed bacterial vaccine in cancer patients.

Havas HF, Axelrod RS, Burns MM, Murasko D, Goonewardene M. Havas HF, et al. Among authors: axelrod rs. Med Oncol Tumor Pharmacother. 1993;10(4):145-58. doi: 10.1007/BF02989663. Med Oncol Tumor Pharmacother. 1993. PMID: 7513036

5

Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.

Werner-Wasik M, Axelrod RS, Friedland DP, Hauck W, Rose LJ, Chapman AE, Grubbs S, Deshields M, Curran WJ. Werner-Wasik M, et al. Among authors: axelrod rs. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):34-9. doi: 10.1053/srao.2002.31361. Semin Radiat Oncol. 2002. PMID: 11917282 Clinical Trial.

6

Effect of the mixed bacterial vaccine on the immune response of patients with non-small cell lung cancer and refractory malignancies.

Axelrod RS, Havas HF, Murasko DM, Bushnell B, Guan CF. Axelrod RS, et al. Cancer. 1988 Jun 1;61(11):2219-30. doi: 10.1002/1097-0142(19880601)61:11<2219::aid-cncr2820611116>3.0.co;2-d. Cancer. 1988. PMID: 2452682

7

A psychoeducational bereavement-support group for families provided in an outpatient cancer center.

Goldstein J, Alter CL, Axelrod R. Goldstein J, et al. J Cancer Educ. 1996 Winter;11(4):233-7. doi: 10.1080/08858199609528435. J Cancer Educ. 1996. PMID: 8989639

8

Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.

Werner-Wasik M, Axelrod RS, Friedland DP, Hauck W, Rose LJ, Chapman AE, Grubbs S, DeShields M, Curran WJ. Werner-Wasik M, et al. Among authors: axelrod rs. Clin Lung Cancer. 2001 May;2(4):284-9; discussion 290. doi: 10.3816/clc.2001.n.011. Clin Lung Cancer. 2001. PMID: 14720361

9

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Movsas B, et al. J Clin Oncol. 2005 Apr 1;23(10):2145-54. doi: 10.1200/JCO.2005.07.167. J Clin Oncol. 2005. PMID: 15800308 Clinical Trial.

10

Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies.

Kubicek GJ, Axelrod RS, Machtay M, Ahn PH, Anne PR, Fogh S, Cognetti D, Myers TJ, Curran WJ Jr, Dicker AP. Kubicek GJ, et al. Among authors: axelrod rs. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1192-7. doi: 10.1016/j.ijrobp.2011.09.023. Epub 2012 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22245208 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page